WAR ON DRUGS

Anthony Bourdain interview on taking LSD

Trudeau Gets Green Light on Legalizing Pot With Retail Sales

Canada got a green light to sell recreational marijuana through a range of retail outlets from an expert panel, whose report boosts the nascent cannabis industry as the country moves toward legalizing the drug.
READ MORE: https://www.bloomberg.com/news/articles/2016-12-13/canada-should-permit-...

Mescaline: its effects on learning rate and dopamine metabolism in goldfish

In 1976 some scientists dosed goldfish up on high doses of mescaline.

The pharmacological action of mescaline on goldfish was studied with the Bitterman-Agranoff shock-avoidance test. In short term experiments with high mescaline doses an increase in learning rates was observed. Similar results were obtained with apomorphine and L-dopa. However, when the fish were exposed to smaller mescaline doses (or to fluphenazine) for 3 days, their ability to avoid electric shock was reduced. Apparently, mescaline induced a release of dopamine which stimulated central dopaminergic systems. Subsequently, MAO destroys the liberated dopamine. Thus, the ensuing dopamine deficit appears to be responsible for the marked changes in behavior in the chronic experiment.
LINK: https://www.ncbi.nlm.nih.gov/pubmed/991995

A Machine That Will Grow Weed In Your Home With No Effort On Your Part

Meet your life changer - Seedo is the first auto grow hydroponics home machine, allowing you to grow herbs and medical plants in-door with no effort at all.

Located in Colorado USA, our team has developed an automatic, human intervention free, growing box machine that automatically control & monitor the process of growing from seed to plants in every given climate, while providing lab conditions in order to maximize production.

Hallucinogen eases depression in cancer patients, studies find

Psilocybin has been illegal in the United States for more than 40 years. But Mihai, who had just finished treatment for Stage 3 Hodgkin’s lymphoma, was participating in a study looking at whether the drug can reduce anxiety and depression in cancer patients. Throughout that eight-hour session, a psychiatrist and a social worker from NYU Langone Medical Center stayed by his side.

Published Thursday, the results from that study, and a similar small, controlled trial, were striking. About 80 percent of cancer patients showed clinically significant reductions in both psychological disorders, a response sustained some seven months after the single dose. Side effects were minimal.
READ MORE: http://www.bostonglobe.com/news/nation/2016/12/01/hallucinogen-eases-dep...

SECRETS OF SUCCESSFUL STEALTH GROWING CANNABIS OUTDOORS

The NZ Police are on the lookout for people growing weed in their backyards and appealing to nosy neighbors to nark on people. If you are gearing up to grow some lovely marijuana plants this summer you should check this out.
STEALTH STICKY BUDS: http://www.growersguidetocannabis.com/stealth-grow-cannabis-outdoors-to-...

British Medical Journal calls for legalisation of drugs

The British Medical Journal has called for the legalisation of illicit drugs for the first time.

Prohibition laws have failed to curb either supply or demand, reduce addiction, cut violence or reduce profits for organised crime, the journal argued, saying the so-called 'War on Drugs' had been a failure.
READ MORE: http://www.independent.co.uk/news/uk/crime/war-on-drugs-british-medical-...

Medicinal cannabis crops now legal in Australia

Budding cannabis producers can now apply for a licence to grow the crop legally in Australia, for medicinal use only.

The Narcotic Drugs Amendment Act 2016, which came into effect on Sunday, allows businesses to apply for a licence to cultivate cannabis or manufacture cannabis products for medicinal purposes, or to conduct related research.
READ MORE: http://www.theage.com.au/national/health/medicinal-cannabis-crops-now-le...

Hallucinogen Therapy Is Coming

Three years later Daniel Kreitman still chokes up when he talks about what he saw, and how it changed him. Kreitman, an upholsterer by trade, had taken psilocybin, a hallucinogen derived from mushrooms, in a trial at Johns Hopkins University School of Medicine for nicotine addiction. He was 52, and he’d smoked between one and two packs a day for nearly 40 years. After his first psilocybin session, his urge to smoke was gone. During his third and final session, he had the vision that helped him quit for good.

Syndicate content